Atria Wealth Solutions Inc. Sells 2,079 Shares of iShares Biotechnology ETF (NASDAQ:IBB)

Atria Wealth Solutions Inc. reduced its stake in iShares Biotechnology ETF (NASDAQ:IBB) by 10.7% during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 17,381 shares of the financial services provider’s stock after selling 2,079 shares during the quarter. Atria Wealth Solutions Inc.’s holdings in iShares Biotechnology ETF were worth $2,298,000 as of its most recent filing with the Securities & Exchange Commission.

Several other hedge funds and other institutional investors also recently made changes to their positions in IBB. Sequoia Financial Advisors LLC increased its holdings in shares of iShares Biotechnology ETF by 8.3% during the third quarter. Sequoia Financial Advisors LLC now owns 2,608 shares of the financial services provider’s stock valued at $380,000 after acquiring an additional 199 shares in the last quarter. Eastern Bank bought a new position in iShares Biotechnology ETF in the 3rd quarter worth about $65,000. Lyell Wealth Management LP increased its stake in iShares Biotechnology ETF by 3.4% during the 3rd quarter. Lyell Wealth Management LP now owns 22,274 shares of the financial services provider’s stock valued at $3,243,000 after purchasing an additional 735 shares in the last quarter. NorthCrest Asset Manangement LLC raised its holdings in iShares Biotechnology ETF by 12.3% in the third quarter. NorthCrest Asset Manangement LLC now owns 3,290 shares of the financial services provider’s stock worth $479,000 after buying an additional 360 shares during the last quarter. Finally, Riggs Asset Managment Co. Inc. lifted its stake in shares of iShares Biotechnology ETF by 1,314.0% in the third quarter. Riggs Asset Managment Co. Inc. now owns 1,513 shares of the financial services provider’s stock worth $220,000 after buying an additional 1,406 shares in the last quarter. Hedge funds and other institutional investors own 62.45% of the company’s stock.

iShares Biotechnology ETF Trading Down 0.4 %

NASDAQ:IBB opened at $138.91 on Friday. The company’s 50 day moving average price is $135.61 and its 200-day moving average price is $140.77. iShares Biotechnology ETF has a 52 week low of $123.60 and a 52 week high of $150.57.

iShares Biotechnology ETF Cuts Dividend

The firm also recently declared a dividend, which was paid on Friday, December 20th. Stockholders of record on Tuesday, December 17th were issued a dividend of $0.0624 per share. The ex-dividend date was Tuesday, December 17th.

iShares Biotechnology ETF Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.